Related Experiment Video
Updated: Jun 19, 2026
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Immunohistochemistry in Kaposi's sarcoma
L Pantanowitz1, C N Otis, B J Dezube
1Department of Pathology, Baystate Medical Center, Tufts University School of Medicine, Springfield, MA, USA. liron.pantanowitz@bhs.org
Insights
Immunohistochemistry (IHC) is crucial for diagnosing and treating Kaposi's sarcoma (KS). This review details how IHC aids in understanding KS development, diagnosis, and identifying new treatment targets.
Area of Science:
- Oncology
- Pathology
- Immunology
Background:
- Kaposi's sarcoma (KS) is a complex disease requiring advanced diagnostic tools.
- Immunohistochemistry (IHC) has become increasingly vital in KS research and clinical practice over recent decades.
Purpose of the Study:
- To review the existing literature on the application of immunohistochemistry (IHC) in the study of Kaposi's sarcoma (KS).
- To highlight the role of IHC in advancing the understanding of KS pathogenesis, diagnosis, and therapeutic strategies.
Main Methods:
- Comprehensive literature review of studies utilizing immunohistochemistry (IHC) in Kaposi's sarcoma (KS) research.
- Analysis of over 100 different primary antibodies employed in IHC for various KS specimen types.
Main Results:
- IHC has been instrumental in elucidating the histogenesis and pathogenesis of KS.
- The technique facilitates accurate diagnosis of KS and has identified novel therapeutic targets.
- Extensive use of diverse antibodies (>100) across various KS specimen types demonstrates IHC's versatility.
Conclusions:
- Immunohistochemistry (IHC) is indispensable for the confident diagnosis and effective treatment of Kaposi's sarcoma (KS).
- Continued application of IHC in KS research will likely yield further insights into disease mechanisms and treatment development.
Abstract:
The importance of immunohistochemistry (IHC) to our understanding, ability to confidently diagnose and treat Kaposi's sarcoma (KS) has grown steadily in the past few decades. IHC has been performed on many KS specimen types, with > 100 different primary antibodies. Therefore, it is not surprising that IHC has helped unravel the histogenesis, understand the pathogenesis and facilitate the diagnosis of KS and identify novel therapeutic targets in the disease. This paper reviews the literature on the use of IHC in the study of KS.
